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Abstract. This paper deals with a system of chemotherapy at home which is 
managed by a Home Care Services (HCS) structure. The main role of this HCS 
structure is to coordinate care actors for a smooth organization of chemotherapy 
at home. In this work, we model a real system of chemotherapy at home 
managed by a HCS structure, and simulate its behaviour. The objective is to 
evaluate the relevance of such a system for current activities of the HCS 
structure, and to propose solutions for improving the optimal coordination of 
the care network for chemotherapy at home. 
Keywords: Care network coordination, Home Care Services, Cancer 
chemotherapy at home, Process modelling, Discrete event simulation  
1   Introduction 
The increased aging population is an important pressure to hospitals, which are 
heavily constrained by their resources to meet growing patient demands, especially 
for patients with severe acute illness and chronic conditions. The fact becomes a main 
motivation and explains the speed development of the Home Care Services (HCS) in 
France. The cancer chemotherapy at home occupies 15.6% of stays in HCS in 2006. 
In this paper, we focus on cancer chemotherapy at home process by referring a 
real-word case study, which can be considered as a care network managed by a 
coordination center. The management performance depends greatly on quality and 
effectiveness of coordination. Therefore, we aim above all to understand the 
chemotherapy at home process and to identify the care actors’ responsibility using 
process modelling method; and then to evaluate quality of coordination of the system 
using discrete event simulation. Based on previous results, we propose two 
improvement procedures, which are simulated. The simulation results are used for a 
comparative analysis. 
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The remainder of the article is organized as follows: In section 2, we give general 
information on the cancer chemotherapy at home. Section 3 describes the studied 
system of chemotherapy at home using process modelling method. Section 4 presents 
the simulation approach with three scenarios; the results of the study are also 
discussed. The article ends with a conclusion of our work. 
2   Development of cancer chemotherapy at home 
The French government encourages the development of chemotherapy at home in 
regarding it as one of the objectives of the Cancer Plan and the reorganization of 
oncology care (Urban, 2006).  
Some existing research works [Dahan & al., 2007] [Boothroyd & al., 2004] show 
that chemotherapy at home is feasible, not only in terms of quality and safety of care, 
but also in terms of patients and their family satisfaction. Urban (2003) points that 
chemotherapy at home only suits valid patients, who are informed and integrated in a 
care program, and who are treated in a suitable family environment. Gorski & al. 
(2008) survey chemotherapy at home and other infusion therapies being realized at 
home; they indicate more clearly the advantages and disadvantages of these 
treatments, especially some critical success factors of their realization at home. 
Chahed & al. (2008) are interested in a drugs delivery problem for a chemotherapy at 
home system. Collomp & al. (2008) propose to use new technologies to facilitate the 
traceability management of products and care actors’ activities in order to improve 
quality of care for chemotherapy at home. Some other researchers [HAS, 2005] 
[Launois, 1996] analyze the economic aspect of the chemotherapy at home and show 
that chemotherapy at home does not seem more expensive than its implementation in 
conventional hospitalization.  
However practices of chemotherapy at home are not much in France, the same for 
research works surveying chemotherapy at home organization process. Our work 
helps to fill this gap.  
3   Chemotherapy at home process modeling: a case study 
In this work, we present a real world case study of the chemotherapy at home. The 
studied system is implemented by a HCS structure situated in the Rhône-Alpes 
province of France. The HCS structure exists for more than thirty years. Today, it 
treats about 250 patients per day, and its operation areas extend across the Rhône 
department and part of the Isere department. They began the chemotherapy at home 
activity in the early 90’s. This activity represents nowadays 3% of the admissions of 
the studied HCS structure. 
Using process modelling method, we analyze the system in detail and divide the 
process into three phases: patient admission phase, home care preparation phase and 
cure realization phase. We present here only the realization phase of chemotherapy at 
home because that is the focus of the whole system. At this stage, we can see different 
internal and external actors really involved for delivering cares or services for patients. 
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The realization process of chemotherapy at home takes here three days; the most 
important activities are only concentrated in the first two days. The last day is used 
for the follow-up post chemotherapy that could be usually carried out by a coordinator 
nurse by phone, or occasionally by a private nurse with a home visit if necessary. A 
simplified model of the process is shown in Figure 1. We simulated the studied 
system based on this model for evaluating system performance. The simulation 
approach and results will be discussed in the next section.  
3.1 Realization process for chemotherapy at home  
The first day of the realization process is devoted to chemotherapy cure validation and 
drugs preparation. Above all, patient’s blood sample has to be analyzed; blood sample 
could be taken by a private nurse or by a city biological laboratory, at patient’s home 
or in the laboratory. And then, the city biological laboratory ensures blood analysis 
and transfers the results to the HCS structure, patient’s family doctor and his hospital. 
The family doctor plays a role of evaluator by understanding the results and 
permitting or not chemotherapy cure realization. If results are normal, the family 
doctor visits the patient at his home and gives chemotherapy validation in signing a 
written order depending on patient’s physical conditions. The validated written order 
is named “Clinical Green Light” (CGL) and will be transmitted to the HCS structure 
by fax. It is received by a coordinator nurse, especially allocated for the chemotherapy 
at home activity. The coordinator nurse shows the CGL to a coordinator doctor in 
order to obtain the final validation of the cure at home, named “Final Green Light” 
(FGL). The FGL is then transferred to the pharmacy of the HCS structure and verified 
by a pharmacist in terms of chemotherapy drugs dosage. The pharmacist gives his 
agreement for drugs preparation by fax with the signed FGL to a contracted hospital 
pharmacy which will prepare chemotherapy drugs corresponding to the defined 
dosage. Simultaneously, pharmacy of the HCS structure ensures other necessary 
medicines preparation. Ideally, chemotherapy drugs production should be finished in 
the first day in late afternoon; in cases of delays, this production must be performed in 
emergency on second day of the process in early morning. 
During the second day of program, a staff delivery person of the HCS structure 
takes firstly the necessary medicines prepared by the HCS structure’s pharmacy, then 
chemotherapy drugs at the hospital pharmacy, and transports them together to 
patient’s home. Delivery verification will be done by an assigned private nurse after 
his arrival at patient’s home. He hereafter prepares the patient for treatments and 
administrates chemotherapy drugs one by one. Treatment durations vary according to 
prescribed chemotherapy protocols. At the end of the cure, the private nurse stays 
with patient for a certain period of time for surveillance. 
3.2 Coordination design presentation  
By looking at the simplified model illustrated in Figure 1, we can observe that 
coordination is necessary all around the realization process. It is ensured by a 
coordinator doctor and a coordinator nurse belonging to the studied HCS structure. 
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The coordinator doctor plays here just a role of supervisor, by overseeing medical 
operations and chemotherapy protocols performance. However, the coordination tasks 
done by the coordinator nurse are very significant for the quality assurance of the 
realization process; she links the different actors (HCS structure, private nurse, city 
biological laboratory, family doctor, hospital pharmacy, …) delivering cares or 
services to a patient, and follows the accomplishment of their activity, accelerating 
them in case of forgetfulness, mistakes and delays. 
 
 
 
Fig. 1. Realization process of chemotherapy at home of the studied HCS structure 
Obviously, the coordinator nurse is deemed as core of the chemotherapy at home 
system, especially for the first two days of the realization process, during which 
various activities must be achieved by different external actors, within a limited time. 
The coordinator nurse must ensure a good sequence for these activities, and an 
efficient communication.  
In the studied system, the main activities are carried out by external actors, but 
coordination is principally guaranteed by a staff nurse of the HCS structure. We thus 
define this system as chemotherapy at home system managed by a coordination 
center. 
4   Simulation approach and results 
Discrete event simulation is a good method for resolving performance evaluation and 
coordination problems. Using this method, we evaluate in this section the studied 
system’s performance, and propose improvement procedures.  
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The presented chemotherapy at home system, managed by a coordination center, 
seems flexible and simple to pilot, but the system performance depends hardly on the 
quality of coordination. Our aim here is to use simulation in order to evaluate firstly 
the quality of coordination for a real system; results are then compared to those of two 
proposed improved scenarios. We restrict our simulations to the first two days of the 
realization process, because they need more coordination tasks, due to the presence of 
concentrated activities. 
4.1   Experiment configuration and validation 
The proposed simulation model, built basing on the realization process of 
chemotherapy at home (Figure 1), includes not only the different necessary activities 
for chemotherapy at home realization, the coordination tasks being ensured by the 
coordinator nurse, but also the uncertainty on the accomplishment dates for some 
activities and decision-making fulfilled by external actors. Data used for building 
simulation model are collected and calculated from direct field observation and 
interviews with care actors. 
 The entities are created according to an analysis of a six months’ patient treatment 
program. Seven chemotherapy protocols are considered. Two hospital pharmacies are 
available for chemotherapy drugs preparation, and one ensures more activities than 
the other. Patients’ homes are dispersed in an area of 80 km around the studied HCS 
structure. 
 Performance indicators chosen for the evaluation of coordination quality are the 
coordination time spent by coordinator nurse and the effect of the coordination design 
on chemotherapy at home organization. 
The experiment period is fixed to three months, and we use a 95% confidence 
interval to validate the relevance of the simulation model. Operation durations of key 
activities are seen as validation factors. Taking into account the stochastic aspects 
related to distribution laws, the simulation model is validated with 30 replications for 
offering reliable results.      
4.2   Simulation scenarios description 
The first simulation scenario concerns actual chemotherapy at home system of the 
studied HCS structure (Scenario 1), in which different external actors ensure only 
their activities for chemotherapy at home realization, but not the communication with 
the HCS structure. Coordination is initialized by coordinator nurse who follows 
activities’ progress and accelerates external actors if necessary, usually by phone. The 
coordination design is supported by a manual way.  
The first improvement solution we propose (Scenario 2) consists in modifying the 
coordination design by redefining actors’ responsibility and eliminating superfluous 
tasks. On the one hand, all the external actors participate to coordination tasks; they 
should inform achievement of their activities to coordinator nurse on their own 
initiative. Instead of verifying, informing and accelerating external actors, the 
coordinator nurse ensures nothing more than information reception and transmission 
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by phone or fax. On the other hand, we notice in the actual model (Figure 1), that 
some tasks are performed twice successively, by two competent actors: chemotherapy 
at home cure is validated by both, the family doctor and the coordinator doctor; 
chemotherapy drugs dosage is verified by the pharmacist of the HCS structure and 
then by hospital pharmacy. We propose here to keep only one actor for each task: 
family doctor for cure validation and hospital pharmacy for drugs dosage verification. 
In the Scenario 3, we recommend the use of new information and communication 
technologies (NICT) to replace the manual way of coordination. Applications of 
NICT in the home care domain are already approved by the literature [Koch, 2006] 
[Collomp & al., 2008] [Tan & al., 2002] [Maglaveras & al., 2002]. In this second 
improvement procedure, we propose a framework of a traceability management of 
actors’ activities, in which several actors are connected by cable network and others 
by mobile network. Patient records are stored in a central server and could be shared 
between different care actors. Information transfers become automatic, accompanied 
by an alert to recipient. The HCS structure, city biological laboratory and hospital 
pharmacy are connected to central server by cable network. A mini pocket pc should 
be assigned to each patient across mobile network. The validation tasks could be done 
by electronic signature that permits the automatic transfer of the necessary 
information to the predetermined recipient. For private nurse and family doctor, their 
electric signatures could be done using the pocket pc assigned to patient. Thus, patient 
has the responsibility to carry the pocket pc always with him for the treatments and to 
provide it to certain care actors (i.e. private nurse, family doctor) if necessary. 
4.3   Results analysis 
In this subsection, we present the results obtained thanks to the simulation of the three 
scenarios described above. A comparative analysis enables to determine the most 
optimal coordination design. The used comparison indicators are coordination time 
spent by coordinator nurse during experiment period for each patient, realization time 
used by each external actor for achieving his activity, and delay ratio depending on 
realization time constraint. For laboratory and family doctor, the realization time is 
composed by an operation time and a variable waiting time before activity execution. 
Results of comparative analysis are showed in Table 1 and Table 2.  
Table 1.  Comparative analysis in terms of coordination time between 3 scenarios  
Scenario Number of patient Coordination time per patient  
Scenario 1 60 47 minutes 
Scenario 2 66 32 minutes 
Scenario 3 63 18 minutes 
 
In Scenario 1, 60 patients are treated by the system during the experiment period; 
coordination nurse devotes 47 minutes per patient for coordination tasks. The 
realization time of each external actor is respectively 175 minutes for private nurse, 
169 minutes for city biological laboratory, 253 minutes for family doctor and 22 
minutes for hospital pharmacy. Ordinarily, family doctor should give the CGL before 
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five o’clock p.m. in the first day of the process, but in 27% of cases, this deadline is 
not respected, which results in delay of chemotherapy drugs preparation in 28% of 
cases.  
66 patients are received in Scenario 2. The coordination time per patient reduces to 
32 minutes. There is no great difference compared with Scenario 1, in terms of 
realization time for most external actors, such as private nurse, city biological 
laboratory and hospital pharmacy. But family doctor uses less time: 187 minutes here 
against 253 minutes in Scenario 1, to fulfill his activity thanks to the first 
improvement solution. In the same way, the delay ratio drops from 27% to 5% for 
giving the CGL by family doctor, and from 28% to 5% for preparing chemotherapy 
drugs by hospital pharmacy. 
Table 2.  Comparative analysis actors between 3 scenarios in terms of realization of external 
actors’ activities 
Actors Activities realization Scenario Scenario 1 Scenario 2 Scenario 3 
Private 
nurse 
Realization time 175 minutes 136 minutes 135 minutes 
Delays (%) 0% 0% 0% 
Laborator
y 
Realization time 169 minutes 165 minutes 55 minutes 
Delays (%) 0% 0% 0% 
Family 
doctor 
Realization time 253 minutes 187 minutes 97 minutes 
Delays (%) 27% 5% 0% 
Hospital 
pharmacy 
Realization time 22 minutes 21 minutes 21 minutes 
Delays (%) 28% 5% 0% 
 
For scenario 3, the system treats 63 patients during the experiment period. The 
coordination time drops to 18 minutes per patient. Thanks to an automatic 
communication way, the waiting time for information transmission is almost 
eliminated; the quality of coordination is thus improved. This way, for two external 
actors mostly concerned by information transfers, namely the city biological 
laboratory and the family doctor, we can observe a reduction of time: 55 minutes only 
for the first, and 97 minutes for the second. The delays observed previously disappear 
here completely. 
To sum up, the current system is not optimal, coordination time is long and delays 
are important. Responsibility redefinition, accompanied with redundant tasks 
elimination, causes quality improvement of coordination and delay reduction for 
certain external actors. As expected, the implementation of a traceability management 
system of actors’ activities permits an optimal coordination and eliminates all the 
delays. Though decline of the delay ratio between Scenario 2 and Scenario 3 is not 
significant (5%), the latter could reduce potential incidents caused by human with 
automatic information transfers; the quality of coordination is more secure, especially 
against a growth of activity in the future. However, other aspects should be designed 
before the system implementation, such as economic aspect and technical aspect, 
which requires further studies. 
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5   Conclusion 
In this work, we are interested in chemotherapy at home system implemented by a 
HCS structure in France. A staff nurse is assigned especially for coordination task to 
ensure a smooth organization. We model and simulate the system to evaluate its 
performance. 
 An optimal coordination design permits less coordination time, which is not 
actually the case for the studied system. We therefore propose to redefine its 
coordination design in the first place and secondly to implement a traceability 
management system of actors’ activities. According to comparative analysis of 
results, the latter leads the most optimal coordination.  
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